CLSP-1025, a first-in-class precision T-cell engager for the treatment of p53 mutant cancers Apr 28 Written By Rachel Swansburg GO BACK TO PRESS RELEASES & MEDIA PresentationApril 27, 2025 CLSP-1025, a first-in-class precision T-cell engager for the treatment of p53 mutant cancers Presentation Rachel Swansburg
CLSP-1025, a first-in-class precision T-cell engager for the treatment of p53 mutant cancers Apr 28 Written By Rachel Swansburg GO BACK TO PRESS RELEASES & MEDIA PresentationApril 27, 2025 CLSP-1025, a first-in-class precision T-cell engager for the treatment of p53 mutant cancers Presentation Rachel Swansburg
